These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26876292)

  • 1. Letter: self-pay behaviour patients with chronic hepatitis C who required direct acting anti-viral urgently in a real-world setting.
    Chen TM; Li YC; Huang PT
    Aliment Pharmacol Ther; 2016 Mar; 43(6):752. PubMed ID: 26876292
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV.
    Zeng QL; Li CX; Zhang DW; Li W; Xu GH; Yu ZJ
    Aliment Pharmacol Ther; 2016 Apr; 43(7):842-3. PubMed ID: 26932414
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of Sofosbuvir and Ribavirin for Eradicating Hepatitis C Virus in Renal Transplant Recipients in Pakistan: Where Resources Are Scarce.
    Hanif FM; Laeeq SM; Mandhwani RK; Luck NH; Aziz T; Mehdi SH
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):63-67. PubMed ID: 28260436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
    Esteban R; Pineda JA; Calleja JL; Casado M; Rodríguez M; Turnes J; Morano Amado LE; Morillas RM; Forns X; Pascasio Acevedo JM; Andrade RJ; Rivero A; Carrión JA; Lens S; Riveiro-Barciela M; McNabb B; Zhang G; Camus G; Stamm LM; Brainard DM; Subramanian GM; Buti M
    Gastroenterology; 2018 Oct; 155(4):1120-1127.e4. PubMed ID: 29958855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.
    Kalal C; Shukla A; Mohanka R; Vora M; Patel P; Shah S
    Hepatology; 2018 May; 67(5):2049-2050. PubMed ID: 29152769
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-acting antivirals response in an acute nosocomial genotype 1b HCV outbreak.
    Benson AA; Wolf D; Lederman N; Safadi R
    Dig Liver Dis; 2018 Jun; 50(6):630-632. PubMed ID: 29628358
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.
    Yoshikawa A; Terashita K; Morikawa K; Matsuda S; Yamamura T; Sarashina K; Nakano S; Kobayashi Y; Sogabe S; Takahashi K; Haba S; Oda H; Takahashi T; Miyagishima T; Sakamoto N
    Clin J Gastroenterol; 2017 Jun; 10(3):270-273. PubMed ID: 28447325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong.
    Lai CL; Wong VW; Yuen MF; Yang JC; Knox SJ; Mo H; Han LL; Brainard DM; Chan HL
    Aliment Pharmacol Ther; 2016 Jan; 43(1):96-101. PubMed ID: 26503414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection.
    Ahmed OA; Kaisar HH; Hawash N; Samir H; Shabana SST; Hassan A Fouad M; Rizk F; Abd-Elsalam S
    Infect Disord Drug Targets; 2017; 17(2):95-100. PubMed ID: 28413993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
    Akhil MS; Kirushnan B; Martin M; Arumugam K; Ganesh Prasad NK; Ravichandran R
    Nephrology (Carlton); 2018 May; 23(5):446-452. PubMed ID: 28339162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    Maciocia N; O'Brien A; Ardeshna K
    N Engl J Med; 2016 Oct; 375(17):1699-1701. PubMed ID: 27783921
    [No Abstract]   [Full Text] [Related]  

  • 14. Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.
    Gane EJ; Shiffman ML; Etzkorn K; Morelli G; Stedman CAM; Davis MN; Hinestrosa F; Dvory-Sobol H; Huang KC; Osinusi A; McNally J; Brainard DM; McHutchison JG; Thompson AJ; Sulkowski MS;
    Hepatology; 2017 Oct; 66(4):1083-1089. PubMed ID: 28498551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
    Tang L; Ward H; Kattakuzhy S; Wilson E; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):21-36. PubMed ID: 26558305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.
    Izzo I; Zanotti P; Chirico C; Casari S; Villanacci V; Salemme M; Biasi L; Festa E; Castelli F
    Infection; 2016 Dec; 44(6):811-812. PubMed ID: 27311809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
    Bourlière M; Adhoute X; Ansaldi C; Oules V; Benali S; Portal I; Castellani P; Halfon P
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1483-94. PubMed ID: 26595560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience.
    Jackson WE; Hanouneh M; Apfel T; Alkhouri N; John BV; Zervos X; Zein NN; Hanouneh IA
    Clin Transplant; 2016 Jun; 30(6):709-13. PubMed ID: 27019204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sofosbuvir and Simeprevir for Treatment of Recurrent Hepatitis C Infection After Liver Transplant.
    Nair S; Satapathy SK; Gonzalez HC
    Exp Clin Transplant; 2017 Jun; 15(3):314-319. PubMed ID: 26926117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Ninja viruses.
    Foster GR
    Hepatology; 2015 Feb; 61(2):421-3. PubMed ID: 25266372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.